Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06139159
Other study ID # R01MD018206
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 10, 2023
Est. completion date August 31, 2027

Study information

Verified date November 2023
Source Drexel University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Latinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, language barriers, low availability of bilingual providers, mental health stigma, and fear of deportation. There is an urgent need to identify low-cost, culturally appropriate interventions to reduce mental health disparities among this population. This project will address that need by implementing and testing CRISOL Mente, a multi-level, culturally-congruent community intervention to improve the mental health of the Latino population in Philadelphia.


Description:

Latinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, cost of services, limited awareness of mental health resources, mental health stigma, and fear of deportation. Limited English proficiency coupled with an acute lack of bilingual and culturally competent providers further impede Latinos' adequate access to quality mental health services. The COVID-19 pandemic has only amplified the need for mental health care and exacerbated mental health disparities for Latino communities, making it urgent to identify low-cost, effective strategies to reduce these gaps. This 5-year project seeks to develop and test a multi-level, community intervention to improve mental health outcomes and promote access to culturally appropriate mental health treatment for Latino communities in Philadelphia. CRISOL Mente will include components at various levels of the socio-ecological model: a clinic-based, stepped-care program relying on Latino lay health workers (LHW) for the delivery of mental health services. To improve mental health symptoms and engagement in care, we will recruit, train and supervise a cohort of Latino LHW who will be embedded into two Latino-serving clinics, extending the reach and effectiveness of the clinics' mental health services. We will compare the impact of three different levels of LHW involvement: a) community outreach/navigation (i.e. screening and referral of community members); b) auxiliary care (i.e. screening, referral, and help overcoming barriers to better mental health); and c) task shifting (i.e. screening, referral, assistance, and supervised delivery of basic mental health treatment). The LHWs will also conduct outreach/education activities in the community (e.g. radio talks, info sessions, tables in community venues) to reduce mental health stigma. Our experienced and largely Latino community-academic research team will also engage in capacity building activities (i.e. monthly town halls, annual retreats, weekly newsletters, provision of trainings and technical support) with the Latino Health Collective, a coalition of Latino-serving organizations. Using mixed-methods and the RE-AIM framework, CRISOL Mente's impact will be evaluated with clinical data, baseline and 6-month patient survey data (N=200 from each level of LHW involvement, total n=600).


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date August 31, 2027
Est. primary completion date August 31, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Ages 18-65 - Fluent in English or Spanish - Self-identification as a member of the Latino community - Resident of Philadelphia, Bucks, Montgomery, Delaware, or Chester County. - Moderate to severe clinical symptoms of anxiety, depression, and/or PTSD Exclusion Criteria: - People with high-risk mental health symptoms: active suicidality, substance use disorder, mania, psychosis, and schizophrenia - People already receiving mental health therapy (in the last 3 months) - Pregnancy

Study Design


Intervention

Other:
Outreach/navigator
Conduct outreach activities with people in the community who are hard to reach and with limited access to health care, conduct informal screening for symptoms of mental illnesses, encourage and refer individuals at-risk, suspected of having, or affected by mental health issues to clinics for triage. Document outreach, screening, and referral activities in LHW database
Auxiliary to care
Arrange consultation for those at-risk, suspected, or affected individuals at clinics for triage. Introduce the patient to the clinical team via a "warm hand-off" and assist in scheduling a follow -up visit. Reviews care plan with patient and help reduce patient and system barriers impeding psychological wellbeing Support patients in achieving management goals; help patients address barriers through education, referral, and navigation to ancillary community services (SAVAME, legal, housing, economic, etc); Engage, activate, and empower patients to participate in the care process Frequent contact with patients: +1 every two weeks during the first 3 months, +1 every month for months 4-6. Assist with group sessions: affinity groups Identify community-based resources. Document outreach, screening, referral, and auxiliary care activities in LHW database
Stepped care and task shifting
Support counselling initiated by the psychologist Reinforce patient education about depression, anxiety, trauma, and other syndemic conditions. Work with patients' families and peers to reduce stigma, address syndemic factors and social conditions. Contact frequency with patients: +1 every two weeks during the first 3 months, +1 every month for months 4-6. Co-lead group sessions: affinity groups Provide Mental Health First Aid to members of the community. Document outreach, screening, referral, auxiliary and stepped care activities in LHW database

Locations

Country Name City State
United States Drexel University School of Public Health Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
Drexel University Esperanza Health Center, The Philadelphia AIDS Consortium

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in mental health symptomatology (depressive, anxiety or post-traumatic stress disorder [PTSD]) Clinically meaningful improvement in symptomatology of at least one of depressive, anxiety symptoms and/or PTSD (composite primary outcome) from baseline to the end of 6 months of treatment.
Where improvement is defined as:
Epidemiologic Studies Depression Scale Revised (CESD-R10) decline of >=30% in the overall score or scoring below the cutoff for depressive disorder, and/or
General Anxiety Disorder-7 (GAD-7) decline of >=30% in the overall score or scoring below the cutoff for anxiety disorder, and/or
PTSD decline of >=30% in the overall score or scoring below the cutoff for PTSD
Baseline to 6 months
Secondary Depressive symptomatology Presence or absence of any clinical mental health disorder will be determined using Center for Measured using Epidemiologic Studies Depression Scale Revised (CESD-R10) for depressive symptoms (continuously) Baseline to 6 months
Secondary Anxiety symptomatology Measured using General Anxiety Disorder-7 (GAD-7) scale for anxiety symptoms (continuosly) Baseline to 6 months
Secondary Post traumatic stress disorder symptomatology Measured using the Short Screening Scale for post-traumatic stress disorder (PTSD). Baseline to 6 months
See also
  Status Clinical Trial Phase
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Recruiting NCT05419934 - EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial N/A
Active, not recruiting NCT04136054 - Better Sleep in Psychiatric Care - Anxiety and Affective Disorders N/A
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT04647318 - Physiological Response to Self-compassion Versus Relaxation N/A
Active, not recruiting NCT05114824 - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students N/A
Recruiting NCT05843695 - Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety N/A
Completed NCT05078450 - Mood Lifters Online for Graduate Students and Young Professionals N/A
Not yet recruiting NCT06162624 - Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons N/A
Not yet recruiting NCT05863637 - Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting N/A
Not yet recruiting NCT05747131 - Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children N/A
Not yet recruiting NCT05225701 - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders. N/A
Completed NCT02579915 - Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC) N/A
Recruiting NCT02376959 - Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers N/A
Recruiting NCT02186366 - Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type N/A
Not yet recruiting NCT02126787 - Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment N/A
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02134730 - School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial N/A
Completed NCT01333098 - Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders Phase 1/Phase 2